Scottish textile technology helps cancer patients

October 15, 2012 in Cancer

Scottish textile technology helps cancer patients

Enlarge

Micro-encapsulated textiles, which offer added comfort as well as aroma-therapeutic benefits to cancer patients, are now being used in a luxury handmade headwear range, Asha.

The range is launched this week by Borders-based textile company, Murray Hogarth, who worked closely on the final product with Heriot-Watt University's School of and Design and South of Scotland Business Solutions (SoSBS).

The turbans, headscarves and accessories in the Asha range, offer a range of finishes such as lavender and other aromatherapy oils and thermo-regulated textiles, aimed at helping cancer patients.

One of the finishes incorporates minute, airtight, hard shell capsules containing a chosen scent being welded to the textile fibre. When the garment is worn, friction causes the capsules to burst, releasing a subtle fragrance, such as aloe vera or lavender.

There are many different types of micro-encapsulated textile finishes, everything from UV ray management and temperature regulation to vitamins and moisturisers, any of which could be incorporated to suit specific needs.

Professor Alison Harley, Head of Heriot-Watt University's School of Textiles and Design, said, "Smart textiles are a fast-developing sector that offers enormous potential within the healthcare industry.

"This collaboration showcases our close work with industry, including many small and medium size textile businesses in Scotland, to help them find ways to add value and grow their business.

"Murray Hogarth is a great example of the ways in which we can help Scottish textile businesses to develop and bring exciting new products to market."

Jim McVee, Business Development Manager at the School of Textiles an Design said, "My brief was to assist Murray Hogarth with the development of a well being garment for women who are having chemo or radiotherapy and which could help with some of the side effects associated with the treatment.

"Fashion Technology at the School developed prototypes and we also recommended that an enhanced finish be added to the fabrics to add further value to the product. This would turn an ordinary garment in to one which would offer the customer different solutions to potential side effects of their treatment. We also helped Murray Hogarth to find a manufacturer who could produce the quantities they needed."

Asha will be supporting Maggie's Cancer Charity by donating 10 per cent of all sales to the charity.

Maggie's Senior Corporate Fundraising Manager, Gemma Branney, said, "Any kind of work or research, such as that carried out by Heriot-Watt University's School of Textiles and Design, to develop to help women with cancer-related hair loss is hugely welcome.

"We are also delighted that Asha are choosing to donate 10% of their sales to Maggie's.

"At Maggie's we rely on the generosity of the communities surrounding our centres to ensure that we can open our doors to support local people affected by cancer. We would like to thank Asha for raising funds to help us keep our doors open."

Provided by Heriot-Watt University search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 1 hour ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 4 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 6 hours ago | popularity not rated yet | comments 0


New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Life expectancy gap widens between those with mental illness and general population

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...